nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS2—bile duct cancer	0.934	1	CbGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—KRT19—bile duct cancer	0.00474	0.0778	CbGpPWpGaD
L-Arginine—NOS2—Alpha9 beta1 integrin signaling events—TNC—bile duct cancer	0.00253	0.0415	CbGpPWpGaD
L-Arginine—SLC7A1—Amino acid and oligopeptide SLC transporters—SLC5A5—bile duct cancer	0.00251	0.0412	CbGpPWpGaD
L-Arginine—NOS3—Effects of Nitric Oxide—NOS2—bile duct cancer	0.00236	0.0387	CbGpPWpGaD
L-Arginine—SLC7A3—Amino acid and oligopeptide SLC transporters—SLC5A5—bile duct cancer	0.00234	0.0383	CbGpPWpGaD
L-Arginine—L-Citrulline—NOS2—bile duct cancer	0.00203	1	CrCbGaD
L-Arginine—SLC7A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—bile duct cancer	0.00148	0.0243	CbGpPWpGaD
L-Arginine—AZIN2—Amino acid and derivative metabolism—SLC5A5—bile duct cancer	0.00145	0.0238	CbGpPWpGaD
L-Arginine—SLC7A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—bile duct cancer	0.00137	0.0226	CbGpPWpGaD
L-Arginine—ASL—Amino acid and derivative metabolism—SLC5A5—bile duct cancer	0.00133	0.0218	CbGpPWpGaD
L-Arginine—ARG2—Amino acid and derivative metabolism—SLC5A5—bile duct cancer	0.0011	0.0181	CbGpPWpGaD
L-Arginine—SLC16A10—Amino acid and oligopeptide SLC transporters—SLC5A5—bile duct cancer	0.00108	0.0176	CbGpPWpGaD
L-Arginine—NOS3—Endothelin Pathways—GNAS—bile duct cancer	0.00104	0.017	CbGpPWpGaD
L-Arginine—NOS3—Nitric oxide stimulates guanylate cyclase—NOS2—bile duct cancer	0.000979	0.0161	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—FAR2—bile duct cancer	0.000963	0.0158	CbGpPWpGaD
L-Arginine—ASL—Metabolism—FAR2—bile duct cancer	0.000881	0.0145	CbGpPWpGaD
L-Arginine—ASS1—Amino acid and derivative metabolism—SLC5A5—bile duct cancer	0.000764	0.0125	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—SMAD4—bile duct cancer	0.000754	0.0124	CbGpPWpGaD
L-Arginine—NOS3—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS2—bile duct cancer	0.000741	0.0122	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—FAR2—bile duct cancer	0.00073	0.012	CbGpPWpGaD
L-Arginine—NOS3—ACE Inhibitor Pathway—TGFB1—bile duct cancer	0.000686	0.0112	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—PTGS2—bile duct cancer	0.000685	0.0112	CbGpPWpGaD
L-Arginine—NOS2—Platelet homeostasis—GNAS—bile duct cancer	0.000672	0.011	CbGpPWpGaD
L-Arginine—SLC7A1—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000661	0.0108	CbGpPWpGaD
L-Arginine—SLC16A10—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—bile duct cancer	0.000633	0.0104	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—MMP9—bile duct cancer	0.000631	0.0104	CbGpPWpGaD
L-Arginine—SLC7A3—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000614	0.0101	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—bile duct cancer	0.000594	0.00975	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—MMP2—bile duct cancer	0.000547	0.00898	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—MMP2—bile duct cancer	0.000527	0.00864	CbGpPWpGaD
L-Arginine—NOS3—Platelet homeostasis—GNAS—bile duct cancer	0.000522	0.00856	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—FAR2—bile duct cancer	0.000506	0.0083	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—MMP2—bile duct cancer	0.000482	0.0079	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—IDH2—bile duct cancer	0.00047	0.00772	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—MMP2—bile duct cancer	0.000467	0.00766	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—GNAS—bile duct cancer	0.000457	0.0075	CbGpPWpGaD
L-Arginine—ASL—liver—bile duct cancer	0.000457	0.154	CbGeAlD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—bile duct cancer	0.000447	0.00733	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—NOS2—bile duct cancer	0.000436	0.00715	CbGpPWpGaD
L-Arginine—ASL—Metabolism—IDH2—bile duct cancer	0.00043	0.00706	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—ERBB2—bile duct cancer	0.000417	0.00684	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—MMP9—bile duct cancer	0.000411	0.00675	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—bile duct cancer	0.000408	0.00669	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—IDH1—bile duct cancer	0.000405	0.00664	CbGpPWpGaD
L-Arginine—NOS3—Platelet homeostasis—NOS2—bile duct cancer	0.000381	0.00625	CbGpPWpGaD
L-Arginine—AZIN2—lymph node—bile duct cancer	0.000377	0.127	CbGeAlD
L-Arginine—NOS3—AGE/RAGE pathway—MMP2—bile duct cancer	0.000374	0.00614	CbGpPWpGaD
L-Arginine—ASL—Metabolism—IDH1—bile duct cancer	0.00037	0.00607	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—NRAS—bile duct cancer	0.000365	0.00599	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—MMP9—bile duct cancer	0.000362	0.00594	CbGpPWpGaD
L-Arginine—NOS2—IL23-mediated signaling events—IL6—bile duct cancer	0.000357	0.00586	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—IDH2—bile duct cancer	0.000357	0.00585	CbGpPWpGaD
L-Arginine—ASL—lymph node—bile duct cancer	0.00035	0.118	CbGeAlD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000336	0.00551	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—NRAS—bile duct cancer	0.000317	0.0052	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—KRAS—bile duct cancer	0.000314	0.00515	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000312	0.00512	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—IDH1—bile duct cancer	0.000307	0.00503	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—GNAS—bile duct cancer	0.000301	0.00494	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—ERBB2—bile duct cancer	0.000296	0.00485	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—EGFR—bile duct cancer	0.000293	0.0048	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—EGFR—bile duct cancer	0.000289	0.00474	CbGpPWpGaD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000288	0.00472	CbGpPWpGaD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000283	0.00464	CbGpPWpGaD
L-Arginine—ASS1—pancreas—bile duct cancer	0.000282	0.0949	CbGeAlD
L-Arginine—NOS3—AGE/RAGE pathway—MMP9—bile duct cancer	0.000281	0.00461	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—bile duct cancer	0.000277	0.00455	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—NRAS—bile duct cancer	0.000276	0.00454	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—KRAS—bile duct cancer	0.000273	0.00448	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—HRAS—bile duct cancer	0.000267	0.00438	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—SLC5A5—bile duct cancer	0.000267	0.00438	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000261	0.00428	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—PTGS2—bile duct cancer	0.000259	0.00425	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—EGFR—bile duct cancer	0.000259	0.00425	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—EGFR—bile duct cancer	0.000252	0.00413	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—IDH2—bile duct cancer	0.000247	0.00405	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—IL6—bile duct cancer	0.000246	0.00403	CbGpPWpGaD
L-Arginine—ASL—Metabolism—SLC5A5—bile duct cancer	0.000244	0.004	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—bile duct cancer	0.000243	0.00398	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000243	0.00398	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—KRAS—bile duct cancer	0.000238	0.0039	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—bile duct cancer	0.000232	0.00381	CbGpPWpGaD
L-Arginine—SLC7A1—lymph node—bile duct cancer	0.000229	0.0772	CbGeAlD
L-Arginine—NOS2—Spinal Cord Injury—MMP9—bile duct cancer	0.000227	0.00373	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—EGFR—bile duct cancer	0.000227	0.00373	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—FAR2—bile duct cancer	0.00022	0.00361	CbGpPWpGaD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000216	0.00355	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—IDH1—bile duct cancer	0.000213	0.00349	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—GNAS—bile duct cancer	0.000207	0.0034	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—SLC5A5—bile duct cancer	0.000202	0.00332	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—HRAS—bile duct cancer	0.000202	0.00332	CbGpPWpGaD
L-Arginine—ARG2—lymph node—bile duct cancer	0.000196	0.0661	CbGeAlD
L-Arginine—NOS3—SHP2 signaling—IL6—bile duct cancer	0.000194	0.00318	CbGpPWpGaD
L-Arginine—ASL—Metabolism—GNAS—bile duct cancer	0.00019	0.00311	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TGFB1—bile duct cancer	0.000187	0.00308	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—EGFR—bile duct cancer	0.000184	0.00302	CbGpPWpGaD
L-Arginine—ASS1—liver—bile duct cancer	0.000179	0.0604	CbGeAlD
L-Arginine—NOS3—liver—bile duct cancer	0.000179	0.0602	CbGeAlD
L-Arginine—NOS3—Corticotropin-releasing hormone—TGFB1—bile duct cancer	0.000178	0.00291	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—NRAS—bile duct cancer	0.000169	0.00278	CbGpPWpGaD
L-Arginine—NOS2—Disease—RNF43—bile duct cancer	0.000165	0.00271	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—HRAS—bile duct cancer	0.000165	0.0027	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—NRAS—bile duct cancer	0.00016	0.00262	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—ERBB2—bile duct cancer	0.00016	0.00262	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GNAS—bile duct cancer	0.000157	0.00258	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TP53—bile duct cancer	0.000154	0.00253	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—GNAS—bile duct cancer	0.000151	0.00247	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000146	0.0024	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—KRAS—bile duct cancer	0.000146	0.00239	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000144	0.00236	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HGF—bile duct cancer	0.000143	0.00235	CbGpPWpGaD
L-Arginine—NOS2—Disease—IDH1—bile duct cancer	0.000142	0.00233	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—IL6—bile duct cancer	0.000141	0.00232	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—SLC5A5—bile duct cancer	0.00014	0.0023	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—KRAS—bile duct cancer	0.000138	0.00226	CbGpPWpGaD
L-Arginine—ASS1—lymph node—bile duct cancer	0.000138	0.0463	CbGeAlD
L-Arginine—NOS3—lymph node—bile duct cancer	0.000137	0.0462	CbGeAlD
L-Arginine—NOS3—Disease—RNF43—bile duct cancer	0.000128	0.00211	CbGpPWpGaD
L-Arginine—SLC16A10—liver—bile duct cancer	0.000128	0.0431	CbGeAlD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—HRAS—bile duct cancer	0.000124	0.00203	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—IL6—bile duct cancer	0.000119	0.00195	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—HRAS—bile duct cancer	0.000117	0.00192	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—GNAS—bile duct cancer	0.000117	0.00192	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000114	0.00186	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—IL6—bile duct cancer	0.000112	0.00184	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000112	0.00183	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HGF—bile duct cancer	0.000111	0.00183	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTGS2—bile duct cancer	0.000111	0.00183	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—EGFR—bile duct cancer	0.000111	0.00182	CbGpPWpGaD
L-Arginine—NOS3—Disease—IDH1—bile duct cancer	0.00011	0.00181	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00011	0.0018	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GNAS—bile duct cancer	0.000109	0.00179	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—IDH2—bile duct cancer	0.000108	0.00176	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—KRAS—bile duct cancer	0.000105	0.00172	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTGS2—bile duct cancer	0.000102	0.00167	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—bile duct cancer	0.000101	0.00165	CbGpPWpGaD
L-Arginine—SLC16A10—lymph node—bile duct cancer	9.82e-05	0.0331	CbGeAlD
L-Arginine—NOS3—Metabolism—IDH1—bile duct cancer	9.25e-05	0.00152	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—IL6—bile duct cancer	9.22e-05	0.00151	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RNF43—bile duct cancer	8.99e-05	0.00148	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—HRAS—bile duct cancer	8.89e-05	0.00146	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—bile duct cancer	8.82e-05	0.00145	CbGpPWpGaD
L-Arginine—SLC22A4—lymph node—bile duct cancer	8.75e-05	0.0295	CbGeAlD
L-Arginine—NOS3—Hemostasis—NOS2—bile duct cancer	8.54e-05	0.0014	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—GNAS—bile duct cancer	8.54e-05	0.0014	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTGS2—bile duct cancer	8.44e-05	0.00138	CbGpPWpGaD
L-Arginine—NOS2—Disease—TGFBR2—bile duct cancer	7.56e-05	0.00124	CbGpPWpGaD
L-Arginine—SLC22A5—liver—bile duct cancer	7.55e-05	0.0254	CbGeAlD
L-Arginine—NOS2—Disease—SMAD4—bile duct cancer	7.16e-05	0.00117	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—NRAS—bile duct cancer	6.29e-05	0.00103	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC5A5—bile duct cancer	6.1e-05	0.001	CbGpPWpGaD
L-Arginine—NOS3—Disease—TGFBR2—bile duct cancer	5.87e-05	0.000963	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTGS2—bile duct cancer	5.85e-05	0.00096	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TGFB1—bile duct cancer	5.85e-05	0.00096	CbGpPWpGaD
L-Arginine—SLC22A5—lymph node—bile duct cancer	5.79e-05	0.0195	CbGeAlD
L-Arginine—NOS3—Disease—SMAD4—bile duct cancer	5.56e-05	0.000912	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—KRAS—bile duct cancer	5.42e-05	0.000889	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—NRAS—bile duct cancer	4.89e-05	0.000802	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—bile duct cancer	4.81e-05	0.00079	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GNAS—bile duct cancer	4.74e-05	0.000778	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HRAS—bile duct cancer	4.6e-05	0.000755	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TGFB1—bile duct cancer	4.54e-05	0.000745	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—KRAS—bile duct cancer	4.21e-05	0.00069	CbGpPWpGaD
L-Arginine—NOS3—Disease—NOS2—bile duct cancer	4.14e-05	0.000678	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TGFBR2—bile duct cancer	4.11e-05	0.000674	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERBB2—bile duct cancer	4.01e-05	0.000657	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GNAS—bile duct cancer	3.97e-05	0.000651	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTGS2—bile duct cancer	3.92e-05	0.000643	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SMAD4—bile duct cancer	3.89e-05	0.000638	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—bile duct cancer	3.74e-05	0.000613	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HRAS—bile duct cancer	3.58e-05	0.000587	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERBB2—bile duct cancer	3.11e-05	0.00051	CbGpPWpGaD
L-Arginine—NOS2—Disease—NRAS—bile duct cancer	3.05e-05	0.0005	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTGS2—bile duct cancer	3.04e-05	0.000499	CbGpPWpGaD
L-Arginine—NOS2—Disease—TGFB1—bile duct cancer	2.83e-05	0.000465	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGFR—bile duct cancer	2.78e-05	0.000455	CbGpPWpGaD
L-Arginine—NOS2—Disease—KRAS—bile duct cancer	2.62e-05	0.00043	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTGS2—bile duct cancer	2.55e-05	0.000418	CbGpPWpGaD
L-Arginine—NOS3—Disease—NRAS—bile duct cancer	2.37e-05	0.000388	CbGpPWpGaD
L-Arginine—NOS2—Disease—HRAS—bile duct cancer	2.23e-05	0.000366	CbGpPWpGaD
L-Arginine—NOS3—Disease—TGFB1—bile duct cancer	2.2e-05	0.000361	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ERBB2—bile duct cancer	2.18e-05	0.000357	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGFR—bile duct cancer	2.16e-05	0.000354	CbGpPWpGaD
L-Arginine—NOS2—Disease—IL6—bile duct cancer	2.13e-05	0.00035	CbGpPWpGaD
L-Arginine—NOS3—Disease—KRAS—bile duct cancer	2.04e-05	0.000334	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MMP9—bile duct cancer	1.87e-05	0.000306	CbGpPWpGaD
L-Arginine—NOS3—Disease—HRAS—bile duct cancer	1.73e-05	0.000284	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NRAS—bile duct cancer	1.66e-05	0.000272	CbGpPWpGaD
L-Arginine—NOS3—Disease—IL6—bile duct cancer	1.66e-05	0.000272	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TGFB1—bile duct cancer	1.54e-05	0.000253	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGFR—bile duct cancer	1.51e-05	0.000248	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KRAS—bile duct cancer	1.43e-05	0.000234	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—bile duct cancer	1.27e-05	0.000208	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRAS—bile duct cancer	1.21e-05	0.000199	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL6—bile duct cancer	1.16e-05	0.00019	CbGpPWpGaD
